Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone: Complete Statistical AnalysisIndependent statistical analysis of Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial: Complete Statistical AnalysisIndependent statistical analysis of Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial:…
- Lingual Endurance Exercise in Treating Post-Stroke Dysphagia: Complete Statistical AnalysisIndependent statistical analysis of Lingual Endurance Exercise in Treating Post-Stroke Dysphagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05523973).
- Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01365910).
- LINK-HF2Independent statistical analysis of LINK-HF2 - Remote Monitoring Analytics in Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04502563).
- LINK: Aftercare Monitoring Project: Complete Statistical AnalysisIndependent statistical analysis of LINK: Aftercare Monitoring Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00265512).
- LinkPositively: A Technology-Delivered Peer Navigation and Social Networking Intervention to Improve HIV Care: Complete Statistical AnalysisIndependent statistical analysis of LinkPositively: A Technology-Delivered Peer Navigation and Social Networking Intervention to Improve HIV Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Lipid Metabolism in Gestational Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Lipid Metabolism in Gestational Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00534105).
- LIPIDS-PIndependent statistical analysis of LIPIDS-P Trial Phase I/II Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03405870).
- Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01315236).
- Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03149887).
- Liposomal Bupivacaine in Implant Based Breast Reconstruction: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine in Implant Based Breast Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02659501).
- Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02349542).
- Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03663283).
- Liposomal Bupivacaine Versus Standard Analgesia in Total Joint Arthroplasty (TJA): Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine Versus Standard Analgesia in Total Joint Arthroplasty (TJA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02197273).
- Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Liposomal Bupivacaine Versus Standard of Care in Total Knee Surgery: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine Versus Standard of Care in Total Knee Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02219087).
- Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Liposomal Bupivacaine vs Dexamethasone ISB: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine vs Dexamethasone ISB: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04047446).
- Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- LIPSIndependent statistical analysis of A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LIPS-A: Lung Injury Prevention Study With Aspirin: Complete Statistical AnalysisIndependent statistical analysis of LIPS-A: Lung Injury Prevention Study With Aspirin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01504867).
- LiquID Guide Catheter Extension Safety Study: Complete Statistical AnalysisIndependent statistical analysis of LiquID Guide Catheter Extension Safety Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05406596).
- Liraglutide in Adolescents With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Liraglutide in Adolescents With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02516657).
- Liraglutide in the Treatment of Type 1 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Liraglutide in the Treatment of Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01722266).
- Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting: Complete Statistical AnalysisIndependent statistical analysis of Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01755416).
- LIREIndependent statistical analysis of Trial of Inserting Prevalence Information Into Lumbar Spine Imaging Reports: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02015455).
- Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients: Complete Statistical AnalysisIndependent statistical analysis of Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): Complete Statistical AnalysisIndependent statistical analysis of Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab: Complete Statistical AnalysisIndependent statistical analysis of Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006): Complete Statistical AnalysisIndependent statistical analysis of Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03483103).
- Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Listening Visits for Emotionally Distressed Mothers of Hospitalized Newborns: Complete Statistical AnalysisIndependent statistical analysis of Listening Visits for Emotionally Distressed Mothers of Hospitalized Newborns: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03704948).
- LITEIndependent statistical analysis of Low InTensity Exercise Intervention in PAD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02538900).
- LithiumIndependent statistical analysis of A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS): primary endpoint results, effect estimate with confidence interval, sample-size…
- Lithium Disilicate (CAD/CAM) Fixed Partial Dentures (FPD) Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of Lithium Disilicate (CAD/CAM) Fixed Partial Dentures (FPD) Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03036566).
- LiTMUSIndependent statistical analysis of Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Litramine in Weight Maintenance: Complete Statistical AnalysisIndependent statistical analysis of Litramine in Weight Maintenance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01505387).
- LITROSIndependent statistical analysis of Lifestyle Intervention and Testosterone Replacement in Obese Seniors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02367105).
- Little Cigar and Cigarillo Warnings for Youth: Complete Statistical AnalysisIndependent statistical analysis of Little Cigar and Cigarillo Warnings for Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06413797).
- Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease – Eye Tracking: Complete Statistical AnalysisIndependent statistical analysis of Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease - Eye Tracking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LittlEarsIndependent statistical analysis of Littlears Auditory Questionnaire: Validation Study in CI Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00785707).
- Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults: Complete Statistical AnalysisIndependent statistical analysis of Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LIVE-PEIndependent statistical analysis of Losartan for Improved Vascular Endothelial Function After Preeclampsia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04632589).